News | Treatment Planning | March 08, 2019

Mississippi Cancer Center Combines RayStation and TomoTherapy for Prostate Cancer Case

Collaboration marks first case in U.S. combining the two technologies

Mississippi Cancer Center Combines RayStation and TomoTherapy for Prostate Cancer Case

March 8, 2019 — Anderson Regional Cancer Center in Meridian, Miss., has treated its first patient using the combination of RaySearch's treatment planning system (TPS) RayStation and Accuray's TomoTherapy Treatment Delivery System. This is the first-ever treatment in the U.S. using the two technologies in combination.

Anderson Regional Cancer Center first began using RayStation in 2013 with its conventional linear accelerators, which provided significant benefits for workflow and patient treatments. The center then added the TomoTherapy System for radiation treatment. Anderson has worked closely with RaySearch and Accuray to join the technologies and is now using RayStation for all radiation treatment planning, which is providing substantial gains in efficiency. Additionally, the high-precision treatment delivery provided by the TomoTherapy System will help ensure the best possible radiation treatments for patients.

The first treatment combining RayStation and TomoTherapy System at Anderson Regional Cancer Center was successfully administered to treat a prostate cancer patient. Moving forward, the center plans to use this combination of TPS and radiation treatment delivery system to also treat cancers of the breast, lung, and head and neck.

Scott Anderson, M.D., radiation oncologist and medical director at Anderson Regional Cancer Center, said: "We have watched these progressive companies develop through the years, and we are all very excited to be at this juncture. Integrating RayStation planning for multiple accelerator platforms enables us to fully embrace the TomoTherapy System's advantages. The future of our patients certainly looks brighter with the ability to unify these developments."

Paul King, chief medical physicist at Anderson Regional Cancer Center, said: "This clinical launch is very significant. It is a big step in an evolving story that has just begun, considering the quality of RayStation's design as it is today, as well as the intensity and direction of its ongoing development."

For more information: www.raysearchlabs.com, www.accuray.com

Related Content

Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Varian Acquiring Cancer Treatment Services International
News | Radiation Therapy | May 21, 2019
Varian Medical Systems announced it has entered into a definitive agreement to acquire India’s Cancer Treatment...
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Blue Earth Diagnostics Expands Access to Axumin in Europe
News | Radiopharmaceuticals and Tracers | May 13, 2019
Blue Earth Diagnostics announced expanded access to the Axumin (fluciclovine (18F)) imaging agent in Europe. The first...
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...